These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Obstetrician-gynecologists and contraception: long-acting reversible contraception practices and education. Luchowski AT; Anderson BL; Power ML; Raglan GB; Espey E; Schulkin J Contraception; 2014 Jun; 89(6):578-83. PubMed ID: 24656553 [TBL] [Abstract][Full Text] [Related]
3. Postabortion contraception: qualitative interviews on counseling and provision of long-acting reversible contraceptive methods. Morse J; Freedman L; Speidel JJ; Thompson KM; Stratton L; Harper CC Perspect Sex Reprod Health; 2012 Jun; 44(2):100-6. PubMed ID: 22681425 [TBL] [Abstract][Full Text] [Related]
4. Did increasing use of highly effective contraception contribute to declining abortions in Iowa? Biggs MA; Rocca CH; Brindis CD; Hirsch H; Grossman D Contraception; 2015 Feb; 91(2):167-73. PubMed ID: 25465890 [TBL] [Abstract][Full Text] [Related]
5. Adherence to Recommended Practices for Provision of Long-Acting Reversible Contraception Among Providers in a Large U.S. Health Care System. Judge-Golden CP; Wiesenfeld HC; Chen BA; Borrero S J Womens Health (Larchmt); 2020 Dec; 29(12):1586-1595. PubMed ID: 32667847 [No Abstract] [Full Text] [Related]
6. Impact of years of clinical experience on perceived contraindications and barriers to the use of LARC: a survey of family planning providers. Philliber AE; Hirsch H; Mortillaro L; Turner R; Arons A; Philliber S Womens Health Issues; 2014; 24(5):503-9. PubMed ID: 25213743 [TBL] [Abstract][Full Text] [Related]
7. Roles of the pharmacist in the use of safe and highly effective long-acting reversible contraception: an opinion of the women's health practice and research network of the American College of Clinical Pharmacy. Rafie S; McIntosh J; Shealy KM; Borgelt LM; Forinash A; Shrader SP; Koepf ER; McClendon KS; Griffin BL; Horlen C; Karaoui LR; Rowe EL; Lodise NM; Wigle PR Pharmacotherapy; 2014 Sep; 34(9):991-9. PubMed ID: 24989020 [TBL] [Abstract][Full Text] [Related]
8. Game change in Colorado: widespread use of long-acting reversible contraceptives and rapid decline in births among young, low-income women. Ricketts S; Klingler G; Schwalberg R Perspect Sex Reprod Health; 2014 Sep; 46(3):125-32. PubMed ID: 24961366 [TBL] [Abstract][Full Text] [Related]
9. The Use of ACOG Guidelines: Perceived Contraindications to IUD and Implant Use Among Family Planning Providers. Philliber AE; Hirsch H; Brindis CD; Turner R; Philliber S Matern Child Health J; 2017 Sep; 21(9):1706-1712. PubMed ID: 28707101 [TBL] [Abstract][Full Text] [Related]
10. Meeting the contraceptive needs of teens and young adults: youth-friendly and long-acting reversible contraceptive services in U.S. family planning facilities. Kavanaugh ML; Jerman J; Ethier K; Moskosky S J Adolesc Health; 2013 Mar; 52(3):284-92. PubMed ID: 23298980 [TBL] [Abstract][Full Text] [Related]
11. Long acting reversible contraception in postpartum adolescents: early initiation of etonogestrel implant is superior to IUDs in the outpatient setting. Tocce K; Sheeder J; Python J; Teal SB J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):59-63. PubMed ID: 22051792 [TBL] [Abstract][Full Text] [Related]
12. Factors influencing the provision of long-acting reversible contraception in California. Biggs MA; Harper CC; Malvin J; Brindis CD Obstet Gynecol; 2014 Mar; 123(3):593-602. PubMed ID: 24499746 [TBL] [Abstract][Full Text] [Related]
13. Accessibility of long-acting reversible contraceptives (LARCs) in Federally Qualified Health Centers (FQHCs). Beeson T; Wood S; Bruen B; Goldberg DG; Mead H; Rosenbaum S Contraception; 2014 Feb; 89(2):91-6. PubMed ID: 24210278 [TBL] [Abstract][Full Text] [Related]
14. Projections and opinions from 100 experts in long-acting reversible contraception. Foster DG; Barar R; Gould H; Gomez I; Nguyen D; Biggs MA Contraception; 2015 Dec; 92(6):543-52. PubMed ID: 26515195 [TBL] [Abstract][Full Text] [Related]
15. Provider attitudes toward dispensing emergency contraception in Michigan's Title X programs. Brown JW; Boulton ML Fam Plann Perspect; 1999; 31(1):39-43. PubMed ID: 10029932 [TBL] [Abstract][Full Text] [Related]
16. Barriers to Receiving Long-acting Reversible Contraception in the Postpartum Period. Zerden ML; Tang JH; Stuart GS; Norton DR; Verbiest SB; Brody S Womens Health Issues; 2015; 25(6):616-21. PubMed ID: 26212318 [TBL] [Abstract][Full Text] [Related]
17. Views of general practitioners on providing contraceptive advice and long-acting reversible contraception at the 6-week postnatal visit: a qualitative study. Lunniss H; Cameron S; Chen ZE J Fam Plann Reprod Health Care; 2016 Apr; 42(2):99-106. PubMed ID: 26311649 [TBL] [Abstract][Full Text] [Related]
18. Counseling for IUDs and implants: are health educators and clinicians on the same page? Thompson KM; Stern L; Gelt M; Speidel JJ; Harper CC Perspect Sex Reprod Health; 2013 Dec; 45(4):191-5. PubMed ID: 24325290 [TBL] [Abstract][Full Text] [Related]
19. Increasing LARC utilization: any woman, any place, any time. Hathaway M; Torres L; Vollett-Krech J; Wohltjen H Clin Obstet Gynecol; 2014 Dec; 57(4):718-30. PubMed ID: 25314089 [TBL] [Abstract][Full Text] [Related]
20. Predictors of long-acting reversible contraception use among unmarried young adults. Dempsey AR; Billingsley CC; Savage AH; Korte JE Am J Obstet Gynecol; 2012 Jun; 206(6):526.e1-5. PubMed ID: 22425402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]